Updated international recommendations (EULAR, 2023) for the treatment of psoriatic arthritis
In recent years, there has been significant progress in the study of psoriatic arthritis (PsA). The possibilities of psoriasis (Ps) and PsA therapy have expanded. The following drugs are used for the treatment of PsA: conventional synthetic disease-modifying antirheumatic drugs (DMARDs); biological...
Saved in:
Main Authors: | Yu. L. Korsakova, T. V. Korotaeva, Sh. Erdes, E. Yu. Loginova, E. L. Nasonov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2024-11-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/3633 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Difficult-to-treat psoriatic arthritis. Data from the All-Russian registry of patients with psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2024-10-01) -
IS PSORIATIC ARTHRITIS REALLY PSORIATIC?
by: Sh. F. Erdes
Published: (2014-12-01) -
Nail disease in psoriatic arthritis. Data from the Russian Psoriatic Arthritis Registry
by: E. E. Gubar, et al.
Published: (2021-10-01) -
Clinical and instrumental characteristics of axial psoriatic arthritis in combination with hyperuricemia
by: Yu. L. Korsakova, et al.
Published: (2024-08-01) -
APREMILAST: AN UPDATE ON ITS EFFICACY AND SAFETY DURING LONG-TERM TREATMENT OF PATIENTS WITH PSORIATIC ARTHRITIS
by: Yu. L. Korsakova, et al.
Published: (2018-11-01)